✦ LIBER ✦

Modulation of gene methylation by genistein or lycopene in breast cancer cells

✍ Scribed by Audrey King-Batoon; Joanna M. Leszczynska; Catherine B. Klein

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 219 KB
Volume: 49
Category: Article
ISSN: 0893-6692
DOI: 10.1002/em.20363

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transcriptional regulation of urokinase

Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: Role of DNA methylation.

✍ Rosie H. Xing; Shafaat A. Rabbani 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB 👁 2 views

Carcinoma of the breast is a leading hormone-dependent malignancy, resulting in a high rate of morbidity and mortality. During the complex multi-step process of tumor promotion, this common cancer is initiated as hormone-responsive (HR), non-metastatic cancer, followed by a gradual transition into a

Modulation of human stromelysin 3 promot

Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells

✍ Athar Ahmad; John F. Marshall; Paul Basset; Patrick Anglard; Ian R. Hart 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 177 KB 👁 2 views

The matrix-degrading enzyme family of matrix-metalloproteinases (MMPs) has been implicated in the process of tumour metastasis. Cellular protein and RNA localisation techniques have been used to show that, whilst several MMP genes are expressed in both cancer and stromal cells, stromelysin 3 is expr

Modulation of suppressor cell activities

Modulation of suppressor cell activities by cyclophosphamide in breast cancer patients

✍ Dr. Katsumasa Kuroi; Yukio Sato; Yoshiyuki Yamaguchi; Tetsuya Toge 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

We investigated the immunomodulatory effect of cyclophosphamide on the induction of suppressor cell activities in peripheral blood lymphocytes. The sera from advanced breast cancer patients as well as concanavalin-A (Con-A) induced suppressor cell activities in lymphocytes from healthy volunteers. P

Expression of the hemochromatosis gene m

Expression of the hemochromatosis gene modulates the cytotoxicity of doxorubicin in breast cancer cells

✍ Christopher R. Chitambar; Srigiridhar Kotamraju; Janine P. Wereley 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 209 KB

## Abstract The antineoplastic agent doxorubicin inhibits cell growth through mechanisms that include an interaction with iron, resulting in the generation of cytotoxic reactive oxygen species (ROS). Prior studies have shown that the wild‐type hemochromatosis gene (wt HFE) may downregulate iron upt

Changes in gene expressions elicited by

Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells

✍ N. Konstantakopoulos; K.G. Montgomery; N. Chamberlain; M.A. Quinn; M.S. Baker; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract The incidence of hormone‐related diseases such as prostatic, breast, ovarian, and endometrial cancer is lower in Asian populations compared to Western countries. High consumption of soybean products that are rich in phytoestrogens, predominantly genistein, is postulated to be responsibl

Identification of a novel breast-cancer-

Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells

✍ Lambert C.J. Dorssers; Jos Veldscholte 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 177 KB 👁 2 views

Development of anti-estrogen resistance limits the benefit of endocrine therapy of breast cancer. The mechanistic basis for resistance to the anti-estrogen tamoxifen may involve (epi)genetic alterations within tumor cells. We have initiated a random search for genes allowing estrogen-dependent ZR-75